Cargando…
Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report
RATIONALE: Heparin-induced thrombocytopenia (HIT) is a common antibody-mediated adverse reaction that occurs after heparin exposure. However, few case reports exist regarding nonantibody-mediated HIT. PATIENT CONCERNS AND DIAGNOSES: An 81-year-old female diagnosed with rapidly progressive glomerulon...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320049/ https://www.ncbi.nlm.nih.gov/pubmed/30558037 http://dx.doi.org/10.1097/MD.0000000000013609 |
_version_ | 1783385158899990528 |
---|---|
author | Liu, Wenxi Zhang, Chao Bai, Qiong Zhang, Zhongliang |
author_facet | Liu, Wenxi Zhang, Chao Bai, Qiong Zhang, Zhongliang |
author_sort | Liu, Wenxi |
collection | PubMed |
description | RATIONALE: Heparin-induced thrombocytopenia (HIT) is a common antibody-mediated adverse reaction that occurs after heparin exposure. However, few case reports exist regarding nonantibody-mediated HIT. PATIENT CONCERNS AND DIAGNOSES: An 81-year-old female diagnosed with rapidly progressive glomerulonephritis (RPGN) presented with atypical presentation of non antibody-meditated HIT after using heparin during hemodialysis. INTERVENTIONS AND OUTCOMES: Patient was initiated on hemodialysis and presented with thrombocytopenia following administration of heparin during dialysis. After ruling out all other causes of thrombocytopenia, HIT was suspected to be the cause. Patient's 4Ts score was 6 points, and Naranjo adverse drug reaction probability scale was a score of 10. However, enzyme-linked immunoassay for platelet factor 4 (PF4)/heparin antibodies was negative, indicating non-antibody mediated HIT. Patient eventually continued hemodialysis without heparin. LESSONS: This patient case presented a rare presentation of HIT type I reaction due to heparin and demonstrated the importance of timely recognition of thrombocytopenia, appropriate diagnosis and management, and possible existence of a new atypical or subtype of HIT reaction. |
format | Online Article Text |
id | pubmed-6320049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-63200492019-01-24 Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report Liu, Wenxi Zhang, Chao Bai, Qiong Zhang, Zhongliang Medicine (Baltimore) Research Article RATIONALE: Heparin-induced thrombocytopenia (HIT) is a common antibody-mediated adverse reaction that occurs after heparin exposure. However, few case reports exist regarding nonantibody-mediated HIT. PATIENT CONCERNS AND DIAGNOSES: An 81-year-old female diagnosed with rapidly progressive glomerulonephritis (RPGN) presented with atypical presentation of non antibody-meditated HIT after using heparin during hemodialysis. INTERVENTIONS AND OUTCOMES: Patient was initiated on hemodialysis and presented with thrombocytopenia following administration of heparin during dialysis. After ruling out all other causes of thrombocytopenia, HIT was suspected to be the cause. Patient's 4Ts score was 6 points, and Naranjo adverse drug reaction probability scale was a score of 10. However, enzyme-linked immunoassay for platelet factor 4 (PF4)/heparin antibodies was negative, indicating non-antibody mediated HIT. Patient eventually continued hemodialysis without heparin. LESSONS: This patient case presented a rare presentation of HIT type I reaction due to heparin and demonstrated the importance of timely recognition of thrombocytopenia, appropriate diagnosis and management, and possible existence of a new atypical or subtype of HIT reaction. Wolters Kluwer Health 2018-12-14 /pmc/articles/PMC6320049/ /pubmed/30558037 http://dx.doi.org/10.1097/MD.0000000000013609 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Research Article Liu, Wenxi Zhang, Chao Bai, Qiong Zhang, Zhongliang Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report |
title | Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report |
title_full | Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report |
title_fullStr | Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report |
title_full_unstemmed | Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report |
title_short | Rare heparin induced thrombocytopenia type I reaction in a hemodialysis patient: Case report |
title_sort | rare heparin induced thrombocytopenia type i reaction in a hemodialysis patient: case report |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320049/ https://www.ncbi.nlm.nih.gov/pubmed/30558037 http://dx.doi.org/10.1097/MD.0000000000013609 |
work_keys_str_mv | AT liuwenxi rareheparininducedthrombocytopeniatypeireactioninahemodialysispatientcasereport AT zhangchao rareheparininducedthrombocytopeniatypeireactioninahemodialysispatientcasereport AT baiqiong rareheparininducedthrombocytopeniatypeireactioninahemodialysispatientcasereport AT zhangzhongliang rareheparininducedthrombocytopeniatypeireactioninahemodialysispatientcasereport |